Please ensure Javascript is enabled for purposes of website accessibility
ORIGINAL PAPER
Incidence trends of invasive and in situ breast cancer among females in Poland during 1999–2014
 
More details
Hide details
1
Department of Epidemiology and Cancer Control, Holycross Cancer Centre, Kielce, Poland
 
2
Faculty of Medical Sciences, School of Economics, Law, and Medical Sciences, Kielce, Poland
 
3
Department of Preventive Medicine, Institute of Translational Epidemiology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, USA
 
4
Cancer Primary Prevention Unit, Department of Cancer Epidemiology, The Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland
 
5
Department of Education, Jan Kochanowski University, Kielce, Poland
 
6
Department of Oncocardiology, Holycross Cancer Centre, Kielce, Poland
 
7
Faculty of Medicine and Health Sciences, Jan Kochanowski University, Kielce, Poland
 
8
Department of Rehabilitation, Holycross Cancer Centre, Kielce, Poland
 
9
Department of Didactics and Research, Holycross Cancer Centre, Kielce, Poland
 
10
Clinic of Clinical Oncology, Holycross Cancer Centre, Kielce, Poland
 
 
Submission date: 2017-03-23
 
 
Final revision date: 2017-10-11
 
 
Acceptance date: 2017-10-11
 
 
Publication date: 2017-12-31
 
 
Medical Studies 2017;33(4):270-278
 
KEYWORDS
TOPICS
ABSTRACT
Introduction: Breast cancer is the most common malignant tumour among females worldwide, including low and middle-income countries. It affects 25% of the female population and yearly is diagnosed in 1.5 million women.
Aim of the research: To determine the trends and distributions for invasive and in situ breast cancer incidence rates between 1999 and 2014 in Poland overall and in the voivodeships with the greatest proportion of females aged ≥ 65 years old.
Material and methods: Data for 226,146 invasive (C50) and 7865 in situ (D05) breast cancer incidence (1999–2014) for all females was obtained from published data of the Polish National Cancer Registry (NCR). Age-standardised rates (ASRs) per 105 person-years for all ages of combined females with 95% confidence intervals (CI) were calculated. Joinpoint regression was performed to identify log-linear trends in both invasive and carcinoma in situ incidence rates in the analysed voivodeships and in Poland overall.
Results: The ASRs of both invasive and in situ breast cancers showed increasing trends over the 1999–2014 period, with different patterns between analysed voivodeships. On average, average annual percent changes (AAPCs) varied from 1.6% to 7.9% annually, while in the Świętokrzyskie Voivodeship AAPCs remained below 0.9% annually.
Conclusions: in situ and invasive breast cancer ASRs in Poland increased between 1999 and 2014. The Annual Percentage Change have slowed since 2004 in the analysed voivodeships, but not in Poland overall. It remains uncertain if breast cancer incidence rates will continue to increase or stabilise over time.
REFERENCES (25)
1.
Yip CH, Buccimazza I, Hartman M, Deo SVS, Cheung PS. Improving outcomes in breast cancer for low and middle income countries. World J Surg 2015; 39: 686-692.
 
2.
Beiki O, Hall P, Ekbom A, Moradi T. Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study. Breast Cancer Res 2012; 14: R5.
 
3.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C. GLOBOCAN 2012 v1. 0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon [online] [cited 2014 04.05]. Globocan Iarc Fr.
 
4.
Jokiel M. Social aspects of breast cancer early detection after introduction of population screenings in Poland. Przegl Epidemiol 2008; 63: 443-447.
 
5.
Liong YV, Hong GS, Teo JG, Lim GH. Breast ductal carcinoma in situ presenting as recurrent non-puerperal mastitis: case report and literature review. World J Surg Oncol 2013; 11: 179.
 
6.
Survival Analysis 2000 – 2007 [online] [cited: 2015 10.30]. Available from: https://w3.iss.it/site/EU5Resu... forms/SA0007.aspx.
 
7.
Sytuacja demograficzna osób starszych i konsekwencje starzenia się ludności Polski w świetle prognozy na lata 2014-2050. Warszawa: Główny Urząd Statystyczny 2014; 1-43.
 
8.
Demographic Yearbook of Poland 2014 [online] [cited: 2015 10.30]. Available from: http://stat.gov.pl/en/topics/s....
 
9.
Raporty Krajowego Rejestru Nowotworów [online] [cited: 2015 03.20]. Available at: http://onkologia.org.pl/raport....
 
10.
Didkowska J, Wojciechowska U, Zatoński W. Nowotwory złośliwe w Polsce w 2011 roku. Cent Onkol Warszawa 2013 [online] [cited: 15 marzec 2015]; Available at: http://onkologia.org.pl/wp-con....
 
11.
Didkowska J, Wojciechowska U, Zatoński W. Prognozy zachorowalności i umieralności na nowotwory złośliwe w Polsce do 2025 roku. Centrum Onkologii – Instytut im. M. Skłodowskiej-Curie, Warsaw 2009.
 
12.
Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351.
 
13.
Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK. Estimating average annual per cent change in trend analysis. Stat Med 2009; 28: 3670-3682.
 
14.
Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 2003; 39: 1718-1729.
 
15.
Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973–1997. Int J Epidemiol 2005; 34: 405-412.
 
16.
Curado MP. Breast cancer in the world: incidence and mortality. Salud Pública México 2011; 53: 372-384.
 
17.
Department of Medical Statistics, National Institute of Hygiene. Health programme for years 1996–2005 [online] [cited: 2015 08.06]. Available at: http://www.medstat.waw.pl/nhp_....
 
18.
Hendrick RE, Smith RA, Rutledge 3rd JH, Smart CR. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials. J Natl Cancer Inst Monogr 1996; 22: 87-92.
 
19.
Syczewska-Weber K, Rucinski P. The main challenges of Polish oncology. Public Health Rep 2008; 123: 655-63.
 
20.
Act of 1 July 2005 on Establishing the Multi-Year “National Cancer Control Programme” [online] [cited 2015 08.06]. Available at: http://www.epaac.eu/from_heidi..._ Programme_English.pdf.
 
21.
Krzyzak M, Maslach D, Juczewska M, Lasota W, Rabczenko D, Marcinkowski JT, Szpak A. Differences in breast cancer incidence and stage distribution between urban and rural female population in Podlaskie Voivodship, Poland in years 2001-2002. Ann Agric Environ Med 2010; 17: 159-162.
 
22.
Kozierkiewicz A, Topór-Mądry R, Śliwczyński A, Pakulski M, Jassem J. Skuteczność i koszty leczenia raka piersi w Polsce: podejście regionalne. Nowotw J Oncol 2014; 64: 24-32.
 
23.
Herman K, Śliwczyński A, Wysocki WM. Wyniki, metody i koszty leczenia raka piersi w Polsce (w latach 2005–2007). Nowotw J Oncol 2014; 64: 33-39.
 
24.
Zatoński W, Przewoźniak K. Ograniczanie zachorowalności i umieralności z powodu chorób nowotworowych. [In:] Zdrowie publiczne i polityka ludnościowa. Rządowa Rada Ludnościowa. Szymborski J (ed.). Warsaw 2012; 78-89.
 
25.
Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-1403.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top